PLYX 8-K 2026-09-14

Polaryx Therapeutics, Inc. (PLYX) 8-K dated 2026-09-14 — accession 0001213900-26-099416.

Polaryx Therapeutics, Inc. (PLYX) common stock.

Polaryx Therapeutics, Inc. filed a 8-K on 2026-09-14. Accession 0001213900-26-099416.

This 8-K covers: Shareholder vote results (Item 5.07). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for PLYX is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The PLYX SEC hub lists recent forms. The stock page is the research view.